-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 7 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 8 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 9 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang - 10 month(s) ago
Derek Kang joins Alicia Morgans to discuss an ongoing exercise study focused on Black patients with prostate cancer undergoing Androgen Deprivation Therapy. This groundbreaking project is designed to study the potential effects of regular exercise on these patients’ physical function, metabolic health, and prostate cancer outcomes. The study hopes to mitigate the higher risk of cardiovascular…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer - 1 year(s) ago
For patients with non-metastatic castration resistant prostate cancer, this clinical trial compared the androgen receptor antagonist flutamide with or without P
Source: OUP AcademicCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice - 1 year(s) ago
This commentary highlights 2 international studies on real-world treatment trends and patterns among patients with metastatic castration-sensitive and resistant
Source: OUP AcademicCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
ASCO GU 2023 study design for the ProTrio trial, patients with prostate cancer on androgen deprivation therapy, risk factor modification program and continuous Fitbit® monitoring, cardiovascular exercise and resistance exercise for prostate cancer patients.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3When to Add ADT to Early or Late Salvage Radiation - Dan Spratt - 1 year(s) ago
Daniel Spratt, MD, reviews the data from two trials that demonstrate the selection of patients for the addition of hormone therapy (ADT) to post-prostatectomy radiation therapy. Dr. Spratt discusses two phase three trials that have evaluated hormonal therapy in the postoperative RP setting with a rising PSA. The RTOG 9601 trial and the GETUG-AFU 16 trial are distinct from each other where the…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
According to Alicia Morgans, MD, MPH, there is a consistent differentiation and benefit when AR-targeted agent is added to the androgen deprivation therapy plus docetaxel backbone.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Harnessing exercise to improve outcomes in Black #ProstateCancer patients. @DKang_PhD @DanaFarber joins @CaPsurvivorship to discuss an ongoing #exercise study focused on Black patients with #PCa undergoing androgen deprivation therapy #ADT > https://t.co/ubWu5CBcqU https://t.co/SdIeYezqCL